コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 strength and base of support during a usual walk.
2 and augmentation index up to 26 h after the walk.
3 at a faster pace, or taking longer-duration walks.
4 of landing probabilities of different length walks.
5 e lateral diffusion from the expected random walks.
6 e collision probabilities of multiple random walks.
7 calculating the coalescence times of random walks.
8 lf-reported subjective estimates of distance walked.
9 ion of neurons with a role in the control of walking.
10 tates relative to the microtubule (MT) while walking.
11 rectionality) but show random bi-directional walking.
12 that was more widespread at rest than during walking.
13 striatum) increased, most prominently during walking.
14 t and adapt to perturbations delivered while walking.
15 eases their risk to fall on their back while walking.
16 circuit for internally monitoring voluntary walking.
17 increased pronation/supination, and knuckle-walking.
18 hin each limb, to velocity-matched tied-belt walking.
19 the signatures of these relationships during walking.
20 these cells could be used to control forward walking.
21 d, in-bed activity, out-of-bed activity, and walking.
22 ely 13-34 strides) after onset of split-belt walking.
26 2 in 3 individuals with cerebral palsy will walk, 3 in 4 will talk, and 1 in 2 will have normal inte
27 correspond to locomotory differences: bottom-walking [5, 6] placodonts have proportionally larger lab
29 approach is suitable to quantify qualitative walking abnormalities related to CNS circuit dysfunction
30 ls were used to compare times to standing or walking across feeding categories while adjusting for pa
31 n factor (AF): 0.93; 95% CI: 0.87, 0.99] and walking (AF: 0.93; 95% CI: 0.88, 0.98) 7% faster than di
32 eloped 'asymmetry linker-mediated nested PCR walking' (ALN-walking) for CNV breakpoint sequencing in
36 e plasma membrane, where dynein captures and walks along astral microtubules to help orient the mitot
37 disassembly at the other end, so that Vps4 'walks' along ESCRT-III until it encounters the ordered N
38 on the provably efficient hit-and-run random walk and crucially uses a preprocessing step to round th
41 y feedback to the spinal motor system during walking and are required for the production of a fluid l
43 scle activity was retained during split-belt walking and was similar, within each limb, to velocity-m
45 ed DNA with one leg and two foot domains for walking, and one arm and one hand domain for picking up
46 l for biological investigations by imaging a walking appendage of Euperipatoides rowelli, a represent
47 n displays a pretelsonic segment bearing non-walking appendages, features as-yet known in all vicissi
48 ails including the chelicerae, five pairs of walking appendages, opisthosomal appendages with book gi
51 encourage active travel (i.e., bicycling and walking) are promising strategies for designing health-p
52 collision risk when walking for recreation, walking at a faster pace, or taking longer-duration walk
56 also increased the oxygen (O2 ) cost of race walking at velocities relevant to real-life race perform
57 ible [9-12] and can alternatively consist of walking backward away from the perceived threat [11], wh
58 ward walking via MDNs and that turning while walking backward might reflect asymmetric activation of
59 show that this capacity is undiminished when walking backward while dragging a heavy food item [3-5].
61 rtant mechanistic neuromuscular insight into walking balance control and important reference values f
63 tal data are explained by a family of random-walk-based models and probabilistic analytical approxima
65 n to the treadmill paradigm with a tethered, walking bee was successful as bees exhibited robust disc
66 up) the median percentage change in distance walked between baseline and 6-month follow-up examinatio
67 e examined associations between individuals' walking bouts and walking risk, measured as mean exposur
69 frequency of hospitalizations, inability to walk, bradykinesia, scoliosis, gastrostomy feeding, age
70 delay during early development (later age at walking), but they were less impaired on certain measure
72 atients returning to preoperative functional walking capacity (6-min walk test) at 4 weeks after surg
74 s no between-group difference in recovery of walking capacity at 4 weeks after surgery [OR 0.77 (95%
78 creased slightly during exoskeleton-assisted walking compared to baseline, while knee flexor activity
79 n on one or both ankles, during a variety of walking conditions, during running, and when optimizing
80 results that vestibular sensory input while walking could be affected through mastoid vibration (MV)
86 SxOA on all-cause mortality through either a walking disability or NSAIDs use was 1.92 (95% CI: 0.86-
88 rdiac index >/=2.5 L.min(-1).m(-2), 6-minute walk distance >440 m, and New York Heart Association cla
89 on respiratory-related impairment (6-minute-walk distance <350 m, modified Medical Research Council
90 th placebo, itMSC therapy increased 6-minute walk distance (+36.47 m, 95% confidence interval 5.98-66
91 ith PAD had a significantly shorter 6-minute-walk distance (356 [108] vs. 422 [103] m, P < 0.001) and
92 onsense mutation DMD and a baseline 6-minute walk distance (6MWD) of 150 m or more and 80% or less of
93 ength and physical performance) and 6-minute walk distance (6MWD), London Chest Activity of Daily Liv
94 95% CI, 0.529 to 1.374; P < 0.001), 6-minute-walk distance (adjusted beta = -10.412; 95% CI, -12.267
95 trozole significantly increased the 6-minute-walk distance (median change = +26 m) compared with plac
96 The primary outcome was change in 6-minute walk distance at 12-week follow-up (minimum clinically i
98 ill exercise significantly improved 6-minute walk distance compared with attention control + placebo,
99 therapy with >/=75-m improvement in 6-minute walk distance compared with patients assigned to optimal
100 M-CSF did not significantly improve 6-minute walk distance more than exercise alone (mean difference,
101 ance (PVR) of at least 400 dyn.s/cm(5) and a walk distance of 150-450 m in 6 min were randomly assign
102 Six-month mean (SE) changes in 6-minute walk distance were 4.6 (8.1) m for the 125-mg resveratro
104 HF-specific quality of life scores, 6-minute walk distance, and NT-proBNP (N-terminal pro-B-type natr
105 ervised treadmill exercise improves 6-minute walk distance, compared with exercise alone and compared
107 Secondary end points were change in 6-minute walk distance, plasma N-terminal pro-B-type natriuretic
108 Changes in FEV1, residual volume, 6-minute-walk distance, St. George's Respiratory Questionnaire sc
110 ng LRF using weight (>/=5% reduction), 6-min-walking distance (>/=10% improvement), and urinary cotin
111 patients demonstrating an increase in their walking distance (median percentage increase of the enti
112 distance (less than versus more than median walking distance, or slow walker versus fast walker) was
114 x, smoking status, alcohol use, daily blocks walked, diuretic use, estimated glomerular filtration ra
115 respiratory and cardiovascular responses of walking down a busy street with high levels of pollution
117 ng things on a crowded shelf), mobility (ie, walking down steps, stairs, or curbs), and driving.
119 displacement of the CoM on oxygen uptake and walking economy without imposing altered gait patterns.
120 (sacrum marker displacement), oxygen uptake, walking economy, stride characteristics and lower limb j
124 e perceived availability of healthy food and walking environment were assessed via surveys, and 1-mil
126 normal physical activity (control; n=145) or walking exercise (n=151); 227 patients (exercise n=104;
128 trial to test whether a simple, personalized walking exercise program at home, managed by dialysis st
129 walking locations was assessed according to walking exposure (duration, distance, and intensity) and
131 imaging and electrophysiology in head-fixed walking flies to identify a different neural population
135 reas with low pedestrian collision risk when walking for recreation, walking at a faster pace, or tak
136 ient experimental approaches (especially ALN-walking) for CNV breakpoint sequencing and highlights th
137 try linker-mediated nested PCR walking' (ALN-walking) for CNV breakpoint sequencing in 49 subjects wi
138 " the expected length of the shortest random walk from any one of the set of sequence-altered genes t
139 ted state in the Markov chain, take a random walk from the presented state for any number of steps.
141 arwin, but the origins of humans' economical walking gait and endurance running capabilities remain u
146 med extensor torque to the knee joint during walking in a multi-week exploratory clinical study.
147 e mechanical work production during barefoot walking in a segment-by-segment manner (hallux, forefoot
148 with high levels of pollution compared with walking in a traffic-free area with lower pollution leve
149 pants, irrespective of their disease status, walking in Hyde Park led to an increase in lung function
151 recordings directly comparing bicycling and walking in Parkinson disease patients with electrodes im
155 Post-intervention, VO2 peak during race walking increased in all groups (P < 0.001, 90% CI: 2.55
158 tic analysis using networks, based on random walks, information diffusion and electrical resistance.
159 essed the effectiveness of a pedometer-based walking intervention in predominantly inactive adults, d
161 ate is an [Formula: see text]-outlier on the walk is significant at [Formula: see text] under the nul
162 EY POINTS: The vestibular influence on human walking is phase-dependent and modulated across both lim
163 without freezing of gait, both bicycling and walking led to a suppression of subthalamic beta power (
164 orpius-type claspers on the first and second walking legs in male individuals of Y. luopingensis indi
165 of pedestrian-vehicle collision in specific walking locations was assessed according to walking expo
166 age during an hourly observation, parks with walking loops had 80% more users (95% CI: 42, 139%), and
175 ethods, we developed a global network random walk model for predicting lncRNA-disease associations (G
180 rmine whether GM-CSF alone improves 6-minute walk more than placebo and whether exercise improves 6-m
181 ong-term frequency drifts governed by random-walk-noise statistics.High-quality optical resonators ha
182 ct's gait was recorded in a gait laboratory, walking normally, with 5 degrees and 10 degrees LWIs, to
184 t observed Pd-catalyzed isomerization ("cage-walking") of B(9)-bromo-meta-carborane during Pd-catalyz
186 ve that a group of anonymous agents randomly walking on a grid are able to estimate their density wit
187 ed visual environment in which tethered bees walking on a spherical treadmill learn to discriminate v
188 s this issue in the context of adaptation to walking on a split-belt treadmill, which can impose a le
190 ivity from areas 5b and 7 of the PPC of cats walking on a treadmill and stepping over a moving obstac
193 r rapidly in everyday activity, such as when walking on sand, suggests the existence of long-term mot
197 ns including the motion of a myosin-V dimer "walking" on an actin fibre, RNA stem-loop packing, and t
199 raffic flows) rather than the probability of walking or biking (i.e., "walkability" or "bikeability")
200 mb occurs rapidly at the onset of split-belt walking, over a shorter time course relative to the char
202 Presenting symptoms were difficulties in walking, pain during exercise, delayed motor milestones
204 crouch gait, a debilitating and inefficient walking pattern marked by excessive knee flexion that wo
207 125 mg/d or 500 mg/d, improves the 6-minute walk performance in patients with peripheral artery dise
208 bility (trunk composite strength: six-minute walk performance, chair stand test, Berg balance perform
209 tional ability (rectus abdominis: six-minute walk performance, chair stand test, sitting and rising t
210 whereas GM-CSF did not significantly improve walking performance, either when used alone or when comb
212 ent self-reported estimates of the distances walked prior to acute illness are subjective and may be
214 ltimeric assemblies, the controllable motors walk processively along actin filaments at speeds of 10-
216 myosin superfamily that, upon dimerization, walks processively toward the pointed end of the actin f
218 n changing speed.SIGNIFICANCE STATEMENT When walking, receptors located in the skin respond to mechan
220 to investigate how PD affects the ability to walk, respond to balance perturbations, and produce acut
221 tions between individuals' walking bouts and walking risk, measured as mean exposure to the risk of p
222 space of "landing probabilities" of a random walk rooted at the seed set, ranking nodes according to
224 ] age, 63.0 [8.2] years) and 1461 adults had walking scores at baseline indicating adequate function
226 It is demonstrated that the updated jump-walking simulations are able to produce equilibrium isot
228 d poor grip strength, exhaustion, and slowed walking speed (hazard ratio, 2.61; 95% CI, 1.14-5.97) we
229 KT recipients with exhaustion and slowed walking speed (hazards ratio = 2.43; 95% CI, 1.17-5.03)
231 h grip strength (Spearman r=-0.57, P<0.005), walking speed (Spearman r=-0.47, P<0.005), and falls (Sp
232 essed as a binary yes or no outcome) or slow walking speed (yes or no) during the 4-year follow-up pe
233 the onset of MLR-HFS, a significantly higher walking speed and improvements in several dynamic gait p
235 od of developing weak grip strength and slow walking speed because purpose has been linked with a ran
238 g Smedley spring-type hand dynamometers, and walking speed was assessed by asking respondents to walk
240 sk of developing weak grip strength and slow walking speed, although the findings were more robust fo
241 impaired activities of daily living, faster walking speed, and favorable objective biomarkers (conce
242 grip strength, poorer lung function, slower walking speed, lower fluid intelligence, higher allostat
243 onal Composite score (a composite measure of walking speed, upper-limb movements, and cognition; for
245 ctivity in the 20-40 Hz range in resting and walking states, and increased interhemispheric coupling
247 ractant not only by biasing their own random-walk swimming pattern through the well-understood intrac
249 roughput and sensitivity by coupling the DNA walking system to Pacific Bioscience(R) Next-generation
251 f 45; P = 0.006) and improvement in 6-minute-walk test (+20.6 m vs. -25.0 m; P = 0.017) at Day 84.
256 art Failure Questionnaire [MLHFQ], and 6-min walk test [6MWT]) were performed at baseline and 30 days
257 as no significant difference in the 6-minute walk test between the inpatient rehabilitation and eithe
259 ore increased (mean: 43.1 to 77.0) and 6-min walk test distance results increased (mean: 163.6 to 252
260 to treatment was assessed using the 6-minute walk test distance, which increased in 25 subjects and d
264 ellar Functional System score, Timed 25-Foot Walk Test, 9-Hole Peg Test (9-HPT), Symbol Digit Modalit
265 aphy, magnetic resonance imaging, a 6-minute walk test, and measurement of natriuretic peptides befor
266 res, and 4990 (10.2%) completed the 6-minute walk test, made available only at the end of 7 days.
267 ving with Heart Failure Questionnaire, 6-min walk test, major adverse cardiac events, and immune biom
270 assessed using clinical scoring of the beam-walking test and video-kinematic analysis (CatWalk) at b
271 The distance covered during the 6-minute walking test improved in the exercise group (mean distan
273 is effect was eliminated in a highly regular walk that sampled exhaustively from images in short, suc
274 formulation and analysis of the "ability to walk the derivative chromosome" signature originally pro
278 ere change from baseline to 6 months in peak walking time (PWT), collateral count, peak hyperemic pop
279 month mean (SE) changes in maximal treadmill walking time were 0.5 (2.3) minutes for the 125-mg resve
281 bute to speed-dependent gait transition from walk, to trot, and then to gallop and bound; the homolat
282 ell motility inside the aggregates, a biased walk toward aggregate centroids, and alignment among nei
284 f 53, P < .001) IVIG treatment, inability to walk unaided (21 [35.0%] of 60 vs 6 [5.3%] of 114, P < .
287 pothesized that LC16 neurons induce backward walking via MDNs and that turning while walking backward
288 We found that the swing phase during LTM walking was slightly enhanced as well as some specific a
290 al cord or after a unilateral hemisection to walk with a precise foot placement on the rungs fixed to
292 develop self-organizing map (SOM) and random walk with restart (RWR) algorithms to separate the proge
294 ics of cortical involvement in human upright walking with a closed-loop BCI has not been investigated
299 ity and base of support were evaluated while walking without cables and reacting to the perturbations
300 y week 120, performance on the timed 25-foot walk worsened by 38.9% with ocrelizumab versus 55.1% wit
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。